Aarey Drugs & Pharmaceuticals Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: AAREYDRUGS BSE: 524412

₹104.07

Oct. 5, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #108 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	427,010	143.5	13.7%	7.6%	—	72	8	30
Divi's Laboratories Limited	244,125	83.0	15.3%	57.8%	0.33%	70	4	51
Torrent Pharmaceuticals Limited	161,506	77.7	12.2%	35.3%	0.80%	56	0	31
Zydus Lifesciences Limited	113,616	32.6	17.3%	14.5%	0.09%	74	24	84
Cipla Limited	107,888	35.1	11.2%	-11.7%	0.97%	73	29	62
Laurus Labs Limited	106,505	122.0	17.1%	128.4%	—	78	24	53
Mankind Pharma Limited	102,382	46.9	11.7%	0.9%	—	68	12	86
Dr. Reddy's Laboratories Limited	100,411	150.9	10.9%	-3.7%	—	62	33	71
Aarey Drugs & Pharmaceuticals Limited (this stock)	295	70.8	3.0%	24.1%	—	42	41	55

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹344 Cr

EV / EBITDA

26.3x

EV / Sales

0.83x

Market cap / Sales

0.71x

Earnings yield

1.41%

Quarterly Financials

Download CSV

Standalone Consolidated

↓ Negative

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 46 Cr, down 55.3% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	45	1	1	₹0.3600
March 31, 2026	189	1	2	₹0.5500
Dec. 31, 2025	96	1	—	₹0.2000
Sept. 30, 2025	84	1	1	₹0.3600
June 30, 2025	102	2	1	₹0.4800
March 31, 2025	108	2	0	₹
Dec. 31, 2024	134	1	1	₹0.2600
Sept. 30, 2024	105	2	2	₹0.5700
June 30, 2024	127	1	1	₹0.4400
March 31, 2024	210	2	2	₹0.7700
Dec. 31, 2023	76	1	1	₹0.4000
Sept. 30, 2023	58	1	1	₹0.3100
June 30, 2023	51	1	1	₹0.2900

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23
Total income (before exceptional items)	46	189	101	85	104	134	105	128	215	77	59	52	164
Operating revenue	45	189	96	84	102	134	105	127	210	76	58	51	158
Other income	2	-0	4	1	2	1	0	2	5	0	1	1	6
Operating expenses	43	185	98	82	101	132	101	126	212	74	56	50	160
Operating profit	1	4	-2	3	2	2	4	1	-1	3	2	1	-2
Operating profit margin	3.0%	2.3%	-1.6%	3.1%	1.7%	1.6%	3.5%	0.9%	-0.7%	3.5%	3.2%	2.6%	-1.4%
Depreciation	1	1	1	1	0	1	0	0	0	0	0	0	0
Interest	2	2	1	1	1	1	2	1	1	1	1	1	1
Exceptional items, gain / (loss)	—	—	—	—	—	—	—	—	—	—	—	—	0
Profit before tax	1	1	1	1	2	1	2	1	2	1	1	1	3
Tax	-1	-0	-0	0	0	1	0	0	-0	0	0	—	1
Net profit	—	—	—	1	—	1	2	1	2	1	1	1	1
EPS	0.36	0.55	0.20	0.36	0.48	0.26	0.57	0.44	0.77	0.40	0.31	0.29	0.14
Net profit (TTM)	—	—	—	—	—	6	6	5	5	4	3	5	5
EPS (TTM)	1.47	1.59	1.30	1.67	1.75	2.04	2.18	1.92	1.77	1.14	0.93	1.45	1.48

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	472	5	4
March 31, 2025	474	6	4
March 31, 2024	396	5	5
March 31, 2023	62	1	0
March 31, 2022	493	10	8

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	89.9%	7.1%	478^†	—	403^†	70^†	495^†	340^†	307^†	359^†	353^†	—
Operating revenue	96.3%	7.2%	472	474	396	62	493	333^†	300^†	355^†	349^†	—
Other income	—	—	6^†	—	7^†	7^†	3^†	7^†	7^†	4^†	3^†	3^†
Operating expenses	—	—	465^†	—	391^†	411^†	481^†	328^†	297^†	—	—	—
Operating profit	—	9.1%	7^†	—	4^†	-349^†	11^†	5^†	3^†	—	—	—
Operating profit margin	—	—	1.5%^†	—	1.1%^†	-558.3%^†	2.3%^†	1.4%^†	1.1%^†	—	—	—
Depreciation	—	—	3^†	—	2^†	2^†	2^†	1^†	1^†	—	—	2^†
Interest	—	—	5^†	—	4^†	3^†	2^†	2^†	2^†	2^†	2^†	4^†
Exceptional items, gain / (loss)	—	—	0^†	—	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†
Profit before tax	93.6%	-8.2%	5	6	5	1	10	8^†	7^†	9^†	8^†	8^†
Tax	—	—	0^†	—	—	—	3^†	—	—	—	—	—
Net profit	100.2%	-8.9%	4	4	5	0	8	6^†	6^†	7^†	6^†	6^†
EPS	2.4%	-10.0%	1.59^†	—	1.77^†	1.48^†	2.76^†	2.70^†	2.48^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	1.5%^†	—	1.1%^†	-558.3%^†	2.3%^†	1.4%^†	1.1%^†	—	—	—
EBIT margin	2.2%^†	—	2.5%^†	5.8%^†	2.5%^†	3.2%^†	3.0%^†	3.2%^†	2.9%^†	—
PBT margin	1.1%	1.3%	1.4%	1.2%	2.0%	2.5%^†	2.4%^†	2.5%^†	2.3%^†	—
Net margin	0.8%	0.8%	1.2%	0.8%	1.5%	1.9%^†	1.9%^†	1.8%^†	1.8%^†	—
Interest coverage	2.08x^†	—	2.22x^†	1.26x^†	5.60x^†	4.41x^†	5.12x^†	5.03x^†	5.36x^†	2.88x^†
Dividend payout	—	—	—	—	—	—	—	—	—	—
Earnings retention	—	—	—	—	—	—	—	—	—	—
Current ratio	1.81x	—	—	—	—	—	—	—	—	—
Quick ratio	1.53x	—	—	—	—	—	—	—	—	—
Debt to equity	0.33x	—	—	—	—	—	—	—	—	—
Return on equity	2.6%	—	—	—	—	—	—	—	—	—
Return on assets	1.3%	—	—	—	—	—	—	—	—	—
Return on capital employed	6.8%^†	—	—	—	—	—	—	—	—	—
Asset turnover	1.59x	—	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	10	-12	2	12	-2
March 31, 2025	10	-6	-4	0	10
March 31, 2024	8	-7	4	0	8
March 31, 2023	-39	11	-23	1	-40
March 31, 2022	19	24	4	-2	21

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	297	150	122	49	1	263	145	1	26	42
March 31, 2025	—	—	—	33	2	—	—	—	16	45
March 31, 2024	—	—	—	—	—	—	—	—	—	—
March 31, 2023	—	—	—	—	—	—	—	—	—	—
March 31, 2022	—	—	—	—	—	—	—	—	—	—

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.